Raymond James & Associates Has $2.76 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Raymond James & Associates cut its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 38.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 63,959 shares of the company's stock after selling 39,140 shares during the quarter. Raymond James & Associates' holdings in Bath & Body Works were worth $2,760,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of BBWI. Front Row Advisors LLC acquired a new position in shares of Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont acquired a new position in shares of Bath & Body Works during the third quarter worth about $27,000. Money Concepts Capital Corp increased its stake in shares of Bath & Body Works by 1,180.4% during the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company's stock worth $28,000 after acquiring an additional 602 shares during the period. Bruce G. Allen Investments LLC acquired a new position in shares of Bath & Body Works during the fourth quarter worth about $44,000. Finally, Dark Forest Capital Management LP increased its stake in shares of Bath & Body Works by 11,890.0% during the first quarter. Dark Forest Capital Management LP now owns 1,199 shares of the company's stock worth $44,000 after acquiring an additional 1,189 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Thomas E. Mazurek sold 4,285 shares of the stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the sale, the insider now owns 45,992 shares of the company's stock, valued at $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on BBWI. Barclays downgraded shares of Bath & Body Works from an "overweight" rating to an "equal weight" rating and boosted their price objective for the stock from $37.00 to $45.00 in a report on Thursday, January 4th. TD Cowen boosted their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. Robert W. Baird boosted their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. UBS Group upped their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a "neutral" rating in a report on Monday, March 4th. Finally, Piper Sandler upped their price target on shares of Bath & Body Works from $44.00 to $45.00 and gave the company a "neutral" rating in a report on Tuesday, April 9th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $46.33.

Bath & Body Works Stock Down 1.4 %

Shares of NYSE:BBWI traded down $0.63 during trading on Monday, reaching $44.59. The stock had a trading volume of 2,047,660 shares, compared to its average volume of 2,795,067. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The business has a fifty day moving average price of $46.19 and a 200-day moving average price of $39.89. The stock has a market cap of $10.03 billion, a P/E ratio of 11.58, a PEG ratio of 1.47 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The firm had revenue of $2.91 billion during the quarter, compared to analyst estimates of $2.84 billion. During the same quarter in the prior year, the business posted $1.86 earnings per share. Bath & Body Works's revenue for the quarter was up .8% compared to the same quarter last year. As a group, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.79%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works's dividend payout ratio (DPR) is 20.78%.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.